Nordion Announces That The Consideration To Be Received By Shareholders Is Increased To US$12.25 In Connection With Its Previously Announced Acquisition

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) today announced that it has entered into an amendment to the previously announced definitive agreement with Sterigenics (the “Arrangement Agreement” and, as amended, the “Amended Arrangement Agreement”) setting out the terms and conditions of the proposed acquisition by Sterigenics of all the issued and outstanding common shares of Nordion. In accordance with the Amended Arrangement Agreement, Nordion shareholders will now be entitled to a cash consideration of US$12.25 per share (the “Increased Consideration”). All other terms of the Arrangement Agreement remain unchanged.

Help employers find you! Check out all the jobs and post your resume.